Morgan Stanley’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,672,825
Closed -$9.48M 8423
2025
Q3
$9.48M Sell
1,672,825
-475,061
-22% -$2.43M ﹤0.01% 3603
2025
Q2
$8.18M Buy
2,147,886
+261,745
+14% +$813K ﹤0.01% 3622
2025
Q1
$4.96M Sell
1,886,141
-23,947
-1% -$78K ﹤0.01% 3937
2024
Q4
$6.76M Buy
1,910,088
+1,577,434
+474% +$6.04M ﹤0.01% 3730
2024
Q3
$1.52M Buy
332,654
+111,363
+50% +$539K ﹤0.01% 4804
2024
Q2
$963K Buy
221,291
+40,571
+22% +$178K ﹤0.01% 4983
2024
Q1
$907K Sell
180,720
-216,452
-54% -$1.21M ﹤0.01% 5009
2023
Q4
$2.49M Sell
397,172
-738,407
-65% -$4.23M ﹤0.01% 4801
2023
Q3
$8.09M Sell
1,135,579
-25,786
-2% -$203K ﹤0.01% 3318
2023
Q2
$11.8M Sell
1,161,365
-6,196
-0.5% -$64.7K ﹤0.01% 3012
2023
Q1
$10.6M Buy
1,167,561
+1,018,583
+684% +$7.46M ﹤0.01% 3093
2022
Q4
$1.07M Buy
148,978
+55,689
+60% +$340K ﹤0.01% 4836
2022
Q3
$608K Sell
93,289
-2,414
-3% -$12.9K ﹤0.01% 5167
2022
Q2
$461K Buy
95,703
+9,118
+11% +$45.1K ﹤0.01% 5461
2022
Q1
$492K Buy
86,585
+11,750
+16% +$57.7K ﹤0.01% 5408
2021
Q4
$375K Buy
74,835
+4,742
+7% +$26.1K ﹤0.01% 5717
2021
Q3
$465K Buy
70,093
+8,929
+15% +$53.4K ﹤0.01% 5544
2021
Q2
$374K Buy
61,164
+6,875
+13% +$41.5K ﹤0.01% 5701
2021
Q1
$361K Buy
54,289
+16,748
+45% +$115K ﹤0.01% 5334
2020
Q4
$199K Buy
37,541
+4,838
+15% +$37.9K ﹤0.01% 5591
2020
Q3
$244K Sell
32,703
-5,606
-15% -$43.8K ﹤0.01% 5006
2020
Q2
$282K Sell
38,309
-2,193
-5% -$19.3K ﹤0.01% 4905
2020
Q1
$300K Sell
40,502
-4,371
-10% -$31.7K ﹤0.01% 4670
2019
Q4
$254K Sell
44,873
-5,051
-10% -$25.8K ﹤0.01% 5308
2019
Q3
$293K Buy
49,924
+36,291
+266% +$205K ﹤0.01% 4944
2019
Q2
$43K Buy
13,633
+3,306
+32% +$10.8K ﹤0.01% 5670
2019
Q1
$31K Sell
10,327
-12,172
-54% -$41.8K ﹤0.01% 5866
2018
Q4
$84K Sell
22,499
-1,108
-5% -$5.21K ﹤0.01% 5613
2018
Q3
$138K Sell
23,607
-52,361
-69% -$267K ﹤0.01% 5592
2018
Q2
$430K Buy
75,968
+52,708
+227% +$542K ﹤0.01% 5198
2018
Q1
$288K Buy
23,260
+18,195
+359% +$245K ﹤0.01% 5305
2017
Q4
$61K Buy
+5,065
New +$71.5K ﹤0.01% 5772